Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antiviral
Pharma
Shionogi's Japan-approved antiviral nets US COVID nod
Shionogi has secured an FDA green light for its Japan-approved COVID-19 antiviral Xocova in the prevention setting.
Fraiser Kansteiner
Jun 1, 2026 11:11am
What 'The Next Berlin Patient' means for HIV drug development
Aug 2, 2024 9:43am
Merck's Lagevrio to be sold commercially in November, HHS says
Oct 5, 2023 10:35am
Shionogi drug to compete with Paxlovid and Lagevrio in Japan
Nov 22, 2022 11:18am
COVID-19 tracker: Pfizer, AstraZeneca, Moderna and more
Aug 31, 2022 11:15am
HHS earmarks $680M for smallpox drug, an Emergent buyout target
Aug 29, 2022 11:50am
